Published in Arch Biochem Biophys on February 01, 1991
Warburg effect in chemosensitivity: targeting lactate dehydrogenase-A re-sensitizes taxol-resistant cancer cells to taxol. Mol Cancer (2010) 1.50
Biochemical characterization and kinetic analysis of duck delta-crystallin with endogenous argininosuccinate lyase activity. Biochem J (1992) 1.01
Analysis of the combined effect of two linear inhibitors on a single enzyme. Biochem J (1998) 0.97
Physiological expression of lens α-, β-, and γ-crystallins in murine and human corneas. Mol Vis (2010) 0.81
Regulation of transcription by a protein methyltransferase. Science (1999) 7.22
Ultralong single-wall carbon nanotubes. Nat Mater (2004) 3.83
The E6 protein of human papillomavirus type 16 binds to and inhibits co-activation by CBP and p300. EMBO J (1999) 2.44
Frequent Imprecise Excision among Reversions of a P Element-Caused Lethal Mutation in Drosophila. Genetics (1984) 2.35
Pain modulation by release of the endogenous cannabinoid anandamide. Proc Natl Acad Sci U S A (1999) 2.31
Synergistic, p160 coactivator-dependent enhancement of estrogen receptor function by CARM1 and p300. J Biol Chem (2000) 2.05
Chromosome rearrangement by ectopic recombination in Drosophila melanogaster: genome structure and evolution. Genetics (1991) 1.96
Estrogen receptor activation function 1 works by binding p160 coactivator proteins. Mol Endocrinol (1998) 1.95
Multiple signal input and output domains of the 160-kilodalton nuclear receptor coactivator proteins. Mol Cell Biol (1999) 1.93
Prognostic value of vascular endothelial growth factor expression in colorectal cancer patients. Eur J Cancer (2000) 1.79
Clinical analysis and literature review of massive duodenal diverticular bleeding. World J Surg (2001) 1.79
Cardiac and glycemic benefits of troglitazone treatment in NIDDM. The Troglitazone Study Group. Diabetes (1997) 1.70
Troglitazone monotherapy improves glycemic control in patients with type 2 diabetes mellitus: a randomized, controlled study. The Troglitazone Study Group. J Clin Endocrinol Metab (1998) 1.44
Clinical pharmacology studies in patients with renal impairment: past experience and regulatory perspectives. J Clin Pharmacol (2000) 1.43
Modulation of transcriptional activation and coactivator interaction by a splicing variation in the F domain of nuclear receptor hepatocyte nuclear factor 4alpha1. Mol Cell Biol (1999) 1.40
Bioavailability and bioequivalence: an FDA regulatory overview. Pharm Res (2001) 1.39
The effects of St John's wort (Hypericum perforatum) on human cytochrome P450 activity. Clin Pharmacol Ther (2001) 1.36
Effects of phosphodiesterase inhibitors on spontaneous electrical activity (slow waves) in the guinea-pig gastric muscle. J Physiol (1995) 1.25
DNA- and protein-scission activities of ascorbate in the presence of copper ion and a copper-peptide complex. J Biochem (1983) 1.22
Optimizing drug development: strategies to assess drug metabolism/transporter interaction potential--toward a consensus. Pharm Res (2001) 1.22
Optimizing drug development: strategies to assess drug metabolism/transporter interaction potential--towards a consensus. Br J Clin Pharmacol (2001) 1.19
Head and neck cancer as a clinical model for molecular targeting of therapy: combining EGFR blockade with radiation. Int J Radiat Oncol Biol Phys (2001) 1.16
Disruption of nNOS-PSD95 protein-protein interaction inhibits acute thermal hyperalgesia and chronic mechanical allodynia in rodents. Br J Pharmacol (2009) 1.11
Expression of vascular endothelial growth factor in normal liver and hepatocellular carcinoma: an immunohistochemical study. Hum Pathol (1997) 1.11
Laparoscopic cholecystectomy for cholelithiasis in a patient with situs inversus totalis. Endoscopy (1992) 1.11
Homocysteine thiolactone induces apoptotic DNA damage mediated by increased intracellular hydrogen peroxide and caspase 3 activation in HL-60 cells. Life Sci (2001) 1.09
Acute colonic intramural hematoma due to blunt abdominal trauma. Int Surg (2000) 1.07
Population pharmacokinetics. A regulatory perspective. Clin Pharmacokinet (1999) 1.07
Haemoglobin, neutrophil to lymphocyte ratio and platelet count improve prognosis prediction of the TNM staging system in nasopharyngeal carcinoma: development and validation in 3,237 patients from a single institution. Clin Oncol (R Coll Radiol) (2013) 1.06
The neurobiology of cannabinoid analgesia. Life Sci (1999) 1.02
Surgical resection of primary hepatocellular carcinoma extending to adjacent organ(s). Eur J Surg Oncol (1996) 1.01
Nonenzymatic glycosylation of bovine lens crystallins. Effect of aging. J Biol Chem (1981) 1.01
Molecular cloning of suppressor of sable, a Drosophila melanogaster transposon-mediated suppressor. Mol Cell Biol (1986) 1.01
Biochemical characterization and kinetic analysis of duck delta-crystallin with endogenous argininosuccinate lyase activity. Biochem J (1992) 1.01
Modulation of molecular targets to enhance radiation. Clin Cancer Res (2000) 0.99
Molecular and genetic organization of the suppressor of sable and minute (1) 1B region in Drosophila melanogaster. Genetics (1989) 0.98
Solution structure of a Kunitz-type chymotrypsin inhibitor isolated from the elapid snake Bungarus fasciatus. J Biol Chem (2001) 0.96
Effects of cromakalim on the electrical slow wave in the circular muscle of guinea-pig gastric antrum. Br J Pharmacol (1993) 0.96
Consequences of metabolic inhibition in smooth muscle isolated from guinea-pig stomach. J Physiol (1997) 0.96
PAUF functions in the metastasis of human pancreatic cancer cells and upregulates CXCR4 expression. Oncogene (2009) 0.95
Significance of c-erbB-2 expression in normal and neoplastic epithelium of biliary tract. Anticancer Res (1995) 0.95
2-Fluoro-4-pyridinylmethyl analogues of linopirdine as orally active acetylcholine release-enhancing agents with good efficacy and duration of action. J Med Chem (1998) 0.94
Recombinant human fibrinogen and sulfation of the gamma' chain. Biochemistry (1991) 0.93
Optimizing drug development: strategies to assess drug metabolism/transporter interaction potential-toward a consensus. Clin Pharmacol Ther (2001) 0.93
Single amino acid changes alter the repair specificity of Drosophila Rrp1. Isolation of mutants deficient in repair of oxidative DNA damage. J Biol Chem (1994) 0.93
Transporter studies in drug development: experience to date and follow-up on decision trees from the International Transporter Consortium. Clin Pharmacol Ther (2013) 0.91
Oncogenic activation of a human cyclin A2 targeted to the endoplasmic reticulum upon hepatitis B virus genome insertion. Oncogene (1998) 0.91
Growth of endothelial cells on different concentrations of Gly-Arg-Gly-Asp photochemically grafted in polyethylene glycol modified polyurethane. Artif Organs (2001) 0.91
A pharmacokinetic evaluation of HIV protease inhibitors, cyclic ureas, in rats and dogs. Biopharm Drug Dispos (1994) 0.90
Effect of heat-induced structural perturbation of secondary and tertiary structures on the chaperone activity of alpha-crystallin. Biochem Biophys Res Commun (1997) 0.90
Characterization, cloning, and expression of porcine alpha B crystallin. Biochem Biophys Res Commun (1998) 0.90
Endocannabinoids in pain modulation. Prostaglandins Leukot Essent Fatty Acids (2002) 0.90
Drosophila Rrp1 complements E. coli xth nfo mutants: protection against both oxidative and alkylation-induced DNA damage. Nucleic Acids Res (1993) 0.89
Characterization of the nuclease activity of Drosophila Rrp1 on phosphoglycolate- and phosphate-modified DNA 3'-termini. Biochemistry (1995) 0.89
Purification and characterization of the cytosolic NADP(+)-dependent malic enzyme from human breast cancer cell line. Eur J Biochem (1991) 0.89
Physiological role of the association complexes of alpha-crystallin and its substrates on the chaperone activity. Biochem Biophys Res Commun (1998) 0.88
Minimal in vivo activation of CYP2C9-mediated flurbiprofen metabolism by dapsone. Eur J Pharm Sci (2001) 0.88
Phylogenetic comparison of lens crystallins from the vertebrate and invertebrate--convergent or divergent evolution? FEBS Lett (1986) 0.88
Affinity cleavage at the putative metal-binding site of pigeon liver malic enzyme by the Fe(2+)-ascorbate system. Biochemistry (1994) 0.88
Characterization of the apurinic endonuclease activity of Drosophila Rrp1. Biochemistry (1993) 0.88
FDA evaluations using in vitro metabolism to predict and interpret in vivo metabolic drug-drug interactions: impact on labeling. J Clin Pharmacol (1999) 0.88
Characterization of three endogenous peptide inhibitors for multiple metalloproteinases with fibrinogenolytic activity from the venom of Taiwan habu (Trimeresurus mucrosquamatus). Biochem Biophys Res Commun (1998) 0.87
Expression of Drosophila Rrp1 protein in Escherichia coli. Enzymatic and physical characterization of the intact protein and a carboxyl-terminally deleted exonuclease-deficient mutant. J Biol Chem (1993) 0.87
Immunoreactive endorphin peptides and prolactin in umbilical vein and maternal blood. Am J Obstet Gynecol (1981) 0.87
Cannabinoids and pain. Pain Res Manag (2001) 0.87
Isolation and physical characterization of bovine lens crystallins. Int J Pept Protein Res (1979) 0.86
Carp gamma-crystallins with high methionine content: cloning and sequencing of the complementary DNA. Biochim Biophys Acta (1988) 0.86
Increased nitric oxide levels in aqueous humor of diabetic patients with neovascular glaucoma. Diabetes Care (1999) 0.86
Functional roles of the N-terminal amino acid residues in the Mn(II)-L-malate binding and subunit interactions of pigeon liver malic enzyme. Protein Eng (1997) 0.85
Specific cleavages of DNA by ascorbate in the presence of copper ion or copper chelates. J Biochem (1985) 0.85
DNA-scission activities of ascorbate in the presence of metal chelates. J Biochem (1984) 0.85
A randomized controlled trial of high-permeability haemodialysis against conventional haemodialysis in the treatment of uraemic pruritus. Clin Exp Dermatol (2009) 0.85
ATRA-induced pseudotumour cerebri--one case report. Kaohsiung J Med Sci (1998) 0.84
Physicochemical characterization of lens crystallins from the carp and biochemical comparison with other vertebrate and invertebrate crystallins. J Biochem (1987) 0.84
Transverse abdominis musculo-peritoneal (TRAMP) flap for the repair of large duodenal defects. J Trauma (1996) 0.84
Implications of serum basic fibroblast growth factor levels in chronic liver diseases and hepatocellular carcinoma. Anticancer Res (1997) 0.84
Cecal perforation presenting as abdominal-wall necrotizing fasciitis. Pediatr Surg Int (2001) 0.84
Homology modeling of cephalopod lens S-crystallin: a natural mutant of sigma-class glutathione transferase with diminished endogenous activity. Biophys J (1999) 0.84
Midpoint back-extrapolation method for the rapid estimation of drugs' volume of distribution and dosage adjustment exhibiting multicompartmental characteristics. Int J Clin Pharmacol Ther Toxicol (1980) 0.84
Synthesis, corticotropin-releasing factor receptor binding affinity, and pharmacokinetic properties of triazolo-, imidazo-, and pyrrolopyrimidines and -pyridines. J Med Chem (1999) 0.84
Reversible dissociation of the catalytically active subunits of pigeon liver malic enzyme. Biochem J (1988) 0.84
Study of structure-activity correlation in destruxins, a class of cyclodepsipeptides possessing suppressive effect on the generation of hepatitis B virus surface antigen in human hepatoma cells. Biochem Biophys Res Commun (1996) 0.84
Characterization of one novel venom protease with beta-fibrinogenase activity from the Taiwan habu (Trimeresurus mucrosquamatus): purification and cDNA sequence analysis. Biochem Biophys Res Commun (1994) 0.84
A comparative study on commercial samples of the roots of Paeonia vitchii and P. lactiflora. Planta Med (1996) 0.84
Radiation response modification following molecular inhibition of epidermal growth factor receptor signaling. Semin Radiat Oncol (2001) 0.83
Mapping of mouse gamma crystallin genes on chromosome 1. Biochem Genet (1988) 0.83
Human placental alkaline phosphatase. An improved purification procedure and kinetic studies. Eur J Biochem (1992) 0.83
Transport and metabolic characterization of Caco-2 cells expressing CYP3A4 and CYP3A4 plus oxidoreductase. Pharm Res (1999) 0.83
Effect of troglitazone on cytochrome P450 enzymes in primary cultures of human and rat hepatocytes. Xenobiotica (2000) 0.83
A comparative study of commercial samples of ephedrae herba. Planta Med (1993) 0.83
Pharmacokinetics of chlorpheniramine after intravenous and oral administration in normal adults. Eur J Clin Pharmacol (1982) 0.83
Vitamin A, Vitamin E or beta-carotene status and hepatitis B-related hepatocellular carcinoma. Ann Epidemiol (1993) 0.82
Superficial parotid lobe-sparing delineation approach: a better method of dose optimization to protect the parotid gland in intensity-modulated radiotherapy for nasopharyngeal carcinoma. Curr Oncol (2013) 0.82
alpha-Crystallin acting as a molecular chaperonin against photodamage by UV irradiation. J Protein Chem (1997) 0.82
Mapping the antigenic epitopes of human dihydrofolate reductase by systematic synthesis of peptides on solid supports. J Biol Chem (1990) 0.82
Heat treatment of incinerator retired sorbents containing heavy metals. Sci Total Environ (2001) 0.82
Involvement of Phe19 in the Mn(2+)-L-malate binding and the subunit interactions of pigeon liver malic enzyme. Biochemistry (1996) 0.82
Cloning and expression of pigeon liver cytosolic NADP(+)-dependent malic enzyme cDNA and some of its abortive mutants. Arch Biochem Biophys (1994) 0.82
Using human plasma supplemented medium to cultivate human bone marrow-derived mesenchymal stem cell and evaluation of its multiple-lineage potential. Transplant Proc (2005) 0.81
Plasma ethanol, endorphin, and glucose experiment. Lancet (1980) 0.81